For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

Otsuka Pharmaceutical and Lundbeck present positive results

Brexpiprazole (Rexulti): Uses, Side Effects, Warnings & More - GoodRx

REXULTI® (brexpiprazole), SZ

Speaking Alzheimer's: A Glossary of Common Terms

FDA Approves Rexulti for Agitation Associated With Dementia Due to

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

New approaches to symptomatic treatments for Alzheimer's disease

FDA nod for Rexulti sNDA in treatment of Alzheimer's agitation

REXULTI® (brexpiprazole) Agitation associated with dementia due

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for

What medications are used to treat Alzheimer's?

Full article: Investigational drugs for treating agitation in

FAQ for agitation that may happen with dementia due to Alzheimer's

REXULTI® (brexpiprazole), MDD